-
AstraZeneca reaches an agreement with the U.S. Department of Labor to resolve race and gender-based pay discrimination among U.S. employees. Between…
-
After being on the market for nearly a year, AstraZeneca sold its U.S. headquarters in Fairfax to a local developer. The $50 million deal between…
-
AstraZeneca’s revenue continues to decline with another double digit drop in the first quarter of 2017.Overall revenue is down 12 percent at $5.4 billion…
-
Federal regulators have signed off on one of AstraZeneca’s most promising cancer drugs for use in the United States. The Food and Drug Administration gave…
-
The British drugmaker, which has its U.S. headquarters just outside Wilmington, said the company saw a 13 percent revenue decline after its cholesterol…
-
An asthma treatment created by AstraZeneca has been granted six months of an extended patent protection by the U.S. Food and Drug Administration, the…
-
AstraZeneca is laying off 120 Delaware employees as part of a larger cut in its workforce.Those layoffs will take place at the pharmaceutical giant’s…
-
Pharmaceutical giant AstraZeneca reports this week its revenue declined by 3 percent in the third quarter of the year. The British drugmaker, which has…
-
AstraZeneca plans to sell its headquarters in Fairfax, but that doesn’t mean it’s moving.The pharmaceutical company announced in May it could move out of…
-
Wilmington-based pharmaceutical giant AstraZeneca is selling part of its antibiotic wing to rival Pfizer for nearly $1.6 billion.The deal includes three…